Two Distinct Components of Vaccination
It is important to note that there are two distinct components of vaccination: the vaccine product and
immunization administration. These two components must be separately recognized and separately paid
at a level that supports ongoing vaccination.
The vaccine product Current Procedural Terminology (CPT
®
) code must be reported to capture expenses
related to the product alone. The product code does not reflect the work and expense that the
immunization administration codes entail. Immunization administration entails separate work,
practice expense, and professional liability insurance expense and is, therefore, separately reportable,
with CPT codes reported either per vaccine (90471–90474) or per component (90460–90461).
Whereas there are no direct vaccine purchase costs for universal purchase states and for publicly
sourced vaccines (VFC and pandemic vaccines), the immunization administration fee must cover
compensation for indirect vaccine acquisition and maintenance expenses, as well as overhead (in
addition to the components already defined in the CPT codes for immunization administration).
Vaccine Product-Related Expenses
To ensure that providers can continue their vital role administering vaccines, the AAP recommends
that payments to providers for the vaccine product should exceed the acquisition cost and overhead
expenses associated with the vaccine product.
4
Nominal immunization administration fees cannot
make up for inadequate vaccine payments due to the separate expenses captured under the product
and administration codes; both need to be appropriately paid by payers.
Following are direct and indirect expenses related to the vaccine product, necessitating payment above
the direct acquisition cost:
Purchase price (acquisition cost) of the vaccine
This is the amount paid by the physician for the vaccine. Although discounts may exist, these are
not available to all pediatric practices and may be time limited. Additionally, larger healthcare
entities often have greater leverage in purchasing power compared to smaller, independent
practices. Cost and payment disparities between pediatric practices cannot be a barrier to
protecting individual and public health.
An accurate and verifiable public source on the current manufacturer's price for vaccines can be
accessed on the CDC vaccine price list for the private sector at
https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html.
The CDC private sector vaccine price list should be used as a transparent methodologic basis for
vaccine acquisition and invoice cost as part of the total cost of the vaccine. In addition, payers
should subscribe to the available email updates on price changes and update their fee schedules
accordingly in a timely manner
4
(within 60 days or as soon as possible based on contractual
requirements, state law, or other requirements).